Japan, July 1 -- NOVARTIS AG has got intellectual property rights for 'NLRP3 INFLAMMASOME INHIBITORS.' Other related details are as follows:
Application Number: JP,2024-160561
Category (FI): A61P11/06,A61P43/00,111,A61P17/10,A61P35/02,A61P35/00,A61P27/02,A61P9/04,A61P17/02,A61P17/00,A61P9/12,A61P9/10,A61P9/00,A61P25/28,A61P13/12,A61P29/00,101,A61P19/06,A61P19/02,A61P1/16,A61P29/00,A61P37/02,A61K45/00,A61K31/5377,A61K31/506,A61K31/50,A61K31/501,C07D451/02,C07D471/04,102,C07D413/12,C07D403/12,C07D237/20,C07D401/12,C07D237/14
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Sept. 18, 2024
Publication Date: Jan. 14, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
